Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATG-037 |
Trade Name | |
Synonyms | ATG037|ATG 037|CB-708|CB708|CB 708 |
Drug Descriptions |
ATG-037 is a small molecule inhibitor of CD73, which may block AMP degradation and potentially lead to reactivation of T-lymphocytes under AMP-mediated immunosuppression (Cancer Res 2022;82(12_Suppl):Abstract nr 2576). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C186654 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATG-037 | ATG-037 | 0 | 1 |
ATG-037 + Pembrolizumab | ATG-037 Pembrolizumab | 0 | 0 |